New hope for stomach cancer: testing powerful drug duos before surgery

NCT ID NCT06731803

Recruiting now Disease control Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest Source: ClinicalTrials.gov ↗

Summary

This study is testing whether new combinations of cancer drugs are safe and effective when given before surgery for a specific type of advanced stomach or esophageal cancer. The trial will involve about 36 patients whose cancer has a specific marker called HER2-positive. The goal is to shrink the tumor with medication first, then remove it with surgery, aiming for better long-term control of the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Charite Universitätsmedizin Berlin
NOT_YET_RECRUITING

Berlin, 13353, Germany

Contact
Hämatologisch-Onkologische Praxis Eppendorf (hope)
NOT_YET_RECRUITING

Hamburg, 20249, Germany

Contact
Klinikum Chemnitz gGmbH
NOT_YET_RECRUITING

Chemnitz, 09116, Germany

Contact
Klinikum Nürnberg
NOT_YET_RECRUITING

Nuremberg, 90419, Germany

Contact
Klinikum rechts der Isar München der TU München
NOT_YET_RECRUITING

München, 81675, Germany

Contact
Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF)
NOT_YET_RECRUITING

Frankfurt am Main, 60488, Germany

Contact
Nationales Centrum für Tumorerkrankungen
NOT_YET_RECRUITING

Heidelberg, 69120, Germany

Contact
Universitätsklinikum Jena
NOT_YET_RECRUITING

Jena, 07747, Germany

Contact
Universitätsklinikum Leipzig
RECRUITING

Leipzig, 04103, Germany

Contact
Universitätsklinikum Ulm
NOT_YET_RECRUITING

Ulm, 89081, Germany

Contact
Universitätsmedizin Halle, Universitätsklinikum Halle (Saale)
NOT_YET_RECRUITING

Halle, 06120, Germany

Contact

Conditions

Explore the condition pages connected to this study.

ESOPHAGOGASTRIC ADENOCARCINOMA